In this study using digital PCR assay as an alternative and non-invasive method for examining plasma and tumor samples, we investigated correlations among T790M mutation, activating EGFR mutations, HER2 amplification, and MET amplification in patients with NSCLC relapse after treatment with EGFR-TKIs. Here, EGFR is linked to neoplasm.